The Oncology Medical Head, International is the senior Medical Affairs leader accountable for defining and executing the international medical strategy for Pfizer’s Oncology portfolio across the full product lifecycle—from early development through post-approval value optimization. The role serves as a core member of the global Oncology Medical Affairs leadership team and is a strategic partner to the Chief Medical Affairs Officer ( International Commercial Division), Regional Global Study Site and Operations (CD&O), Global Clinical Development, International Commercial, Access, Public Policy and Country Medical organizations to deliver patient-centered, evidence-driven medical impact globally. 

This position combines deep oncology clinical and scientific expertise with enterprise leadership to ensure patient-centered, evidence-driven decisions; consistent interpretation and communication of oncology data; and high-quality medical execution across regions. The Oncology Medical Head, International models Pfizer values and behaviors, scientific integrity, and a strong compliance mindset while building a culture of excellence, inclusion, and continuous improvement.

JOB RESPONSIBILITIES

Duties and responsibilities may be delegated as appropriate; however, the Oncology Medical Head, International retains accountability for outcomes. Responsibilities include, but are not limited to:

• Own and evolve the international medical strategy for assigned Oncology programs and disease areas, aligned to global Oncology strategy and regional patient needs.
• Translate oncology clinical, translational, and real-world evidence into clear strategic implications for patient outcomes, benefit–risk, and value communication.
• Represent and advocate for the international medical perspective in integrated asset and disease strategies with Global Medical, Clinical Development, Safety, Regulatory, Commercial, and Access/HV&E.
• Ensure the international patient and clinician voice is incorporated into development, lifecycle, and evidence generation plans, including unmet need, treatment pathways, and meaningful outcomes.
•  Define and integrate international needs into the Integrated Evidence and Lifecycle plans, including indication expansion, sequencing/combination strategy, line-of-therapy positioning, and differentiation narrative across international markets.

• Set clear scientific objectives and success metrics for medical plans, ensuring focus, prioritization, and measurable impact.

• Engages and leads interactions with clinical and research leaders (experts) including academicians, clinical physicians, medical directors, directors of pharmacy and other health care professionals aligned with brand medical objectives

• Provides medical expertise in the medical/scientific assessment of potential business development activities and pre-proof of concept compounds being considered for the International Oncology organization
• Influences decisions in the organization of external meetings including advisory boards, congress and symposium as appropriate and seeking active feedback for continuous improvement

• Lead the team of international medical scientific experts for assigned assets, ensuring consistency of data interpretation and communication across regions and functions.
• Develop and maintain a clear, credible oncology scientific narrative (including mechanism, clinical evidence, safety profile, and patient value) tailored to different audiences while remaining compliant.
• Partner with internal stakeholders to drive alignment on key medical messages, and proactively resolve scientific ambiguities or disagreements.
• Provide medical oversight for scientific content, training, FAQs, and congress materials to ensure accuracy, balance, and consistency.
• Ensure country-aligned medical input into global brand strategy and execution while safeguarding scientific integrity and separation of roles as required.

• Engage on a peer basis with international and regional oncology experts (academics, investigators, clinicians, pharmacists, and healthcare system leaders) to inform strategy and improve patient care.
• Establish and sustain strategic relationships with independent networks and healthcare-providing entities to co-develop medically appropriate solutions that enhance patient outcomes.
• Lead the strategy for advisory boards, expert panels, and scientific meetings—defining objectives, ensuring high-quality insights, and closing the loop with action and communication.
• Represent Pfizer Oncology Medical Affairs in scientific partnerships and collaborative initiatives, ensuring governance, transparency, and compliance.
• Promote a culture of listening to the medical community and translating insights into actionable, evidence-based medical plans.

• Lead the international Tumor Leads to engage in the integrated evidence generation strategy for assigned assets, including clinical, observational, RWE, and outcomes research aligned to key medical questions.
• Help identify and prioritize evidence gaps across international markets (e.g., comparative effectiveness, sequencing, special populations, implementation science) and prioritize studies to close gaps.
• Lead & prioritize the International New Data Generation projects as per Operational cycle budget planning
• Define and lead the Investigator-Initiated Research (IIR) international strategy, including prioritization, scientific review input, and portfolio governance, aligned to medical objectives.
• Ensure timely dissemination of high-impact oncology evidence through congresses and peer-reviewed publications, supporting appropriate uptake and understanding of data.

• Deliver medical activities in support of asset operating plans within agreed time, cost, and quality parameters; manage resources required to deliver such activities.
• Lead planning and timely execution of medical tactics that support country strategies and lifecycle plans, enabling consistent, high-quality international implementation.
• Understand and facilitate local medical activities across regions; remove barriers and drive best-practice sharing across the international network.
• Proactively identify business challenges and generate strategic medical solutions grounded in oncology insights and evidence.
• Influence decision-making for external meetings (advisory boards, congresses, symposia) and ensure feedback and continuous improvement.
• Support patient access and public policy initiatives across the international region
• Lead & coordinate international medical support to global clinical trials
• Establish and track performance indicators (KPIs) for medical plan delivery and outcomes; use data to prioritize, learn, and optimize.

• Build a high-performing, inclusive team culture that encourages coaching, collaboration, continuous learning, and constructive challenge.
• Coach colleagues before and after key meetings to elevate performance and strengthen scientific communication and stakeholder engagement.
• Demonstrate enterprise leadership—anticipating needs, fulfilling expectations, and building trust across senior stakeholders globally.
• Lead effectively within a complex matrix, influencing without authority and aligning stakeholders to shared goals and priorities.
• Role model ethics, integrity, and compliance; ensure all medical activities adhere to Pfizer policies and applicable laws/regulations.

• Demonstrate proficiency with digital and AI-enabled tools to improve medical insight generation, evidence synthesis, operational efficiency, and stakeholder engagement—while maintaining appropriate governance, privacy, and compliance.
• Apply data literacy to interpret and communicate oncology evidence (clinical trial data, RWE, and safety data) and to evaluate signal versus noise in complex datasets.
• Champion responsible use of generative AI and analytics for medical writing support, literature surveillance, and knowledge management, ensuring human oversight, scientific accuracy, and adherence to policies.
• Partner with digital, analytics, and data science teams to identify high-value use cases and scale solutions that improve patient impact and medical productivity.
• Continuously upskill self and team on emerging digital and AI capabilities relevant to oncology medical affairs.

• MD, MD/PhD (or equivalent); specialty training and/or substantial experience in Oncology/hematology-oncology strongly preferred.
• Demonstrated depth in translational and/or clinical oncology evidence generation and interpretation.
• Significant relevant work experience (typically 9+ years) with deep exposure to oncology clinical and/or translational science.
• Proven leader of complex, global cross-functional teams, with the ability to align senior stakeholders and drive execution across highly matrixed environments.
• Direct experience leading or playing a central role in global product launches, with strong understanding of regional (ex‑US) dynamics including regulatory, access, and commercialization considerations.
• Track record of owning and shaping product strategy across the lifecycle, from late-stage development through approval and launch, integrating clinical, regulatory, and commercial perspectives.
• Strong strategic thinker with demonstrated ability to make high-impact decisions in complex, ambiguous environments, balancing risk, speed, and long-term value
• Experience engaging with global health authorities and external experts, with credibility to represent programs at senior and executive levels.
• Recognized people leader who builds and inspires high-performing, globally distributed teams, fostering a culture of accountability, collaboration, and continuous improvement.

Relocation assistance may be available based on business needs and/or eligibility.

Candidates must be authorized to be employed in the U.S. by any employer.

U.S. work visa sponsorship (such as TN, O-1, H-1B, etc.) is not available for this role now or in the future.